Active, not recruitingPhase 2NCT03937843
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Studying Tumor of testis and paratestis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Swiss Cancer Institute
- Principal Investigator
- Alexandros Papachristofilou, MDUniversitätsspital Basel
- Intervention
- Carboplatin(drug)
- Enrollment
- 135 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2019 – 2046
Study locations (19)
- Rotkreuzklinikum München, München, München, Germany
- Vivantes Klinikum Am Urban, Berlin, Germany
- Helios Klinikum Berlin-Buch, Berlin, Germany
- Evang. Kliniken Essen-Mitte, Essen, Germany
- Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
- ASKLEPIOS Kliniken, Hamburg, Germany
- RKH Klinikum Ludwigsburg, Ludwigsburg, Germany
- Universitätsklinikum Tübingen, Tübingen, Germany
- Universitätsklinikum Ulm, Ulm, Germany
- Universitaetsspital-Basel, Basel, Switzerland
- Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, Switzerland
- Inselspital Bern, Bern, Switzerland
- Kantonsspital Graubuenden, Chur, Switzerland
- Kantonsspital Graubünden, Chur, Switzerland
- Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Switzerland
- +4 more locations on ClinicalTrials.gov
Collaborators
German Testicular Cancer Study Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03937843 on ClinicalTrials.govOther trials for Tumor of testis and paratestis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06593665Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.Indiana University
- RECRUITINGPHASE2NCT06144736PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLNDHeinrich-Heine University, Duesseldorf
- RECRUITINGNCT05564026Molecular Epidemiology of Pediatric Germ Cell TumorsChildren's Oncology Group
- RECRUITINGPHASE2NCT05529251De-escalation Study for Stage IIa/IIb < 3 cm SeminomaCentre Leon Berard
- RECRUITINGNANCT04113122Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT StudyUniversity Medical Center Groningen
- ACTIVE NOT RECRUITINGPHASE2NCT03158064Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGNANCT01049230Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell TumorsMassachusetts General Hospital